The Potential Clinical Benefit of Targeting Androgen Receptor (Ar) in Estrogen-Receptor Positive Breast Cancer Cells Treated with Exemestane
AuthID
P-00R-M4V
P-00R-M4V
© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service